International Healthcare & Biotech Media
Insights into China innovative drugs, oncology breakthroughs, and international patient care.
15 Articles
2026-06-09
Off-label drug use has become increasingly common in oncology, rare diseases, pediatrics, and precision medicine. Understanding its benefits, risks, and regulatory framework can help patients make more informed treatment decisions.
2026-06-09
Understanding overseas medical costs, international health insurance, reimbursement rules, and strategies to reduce financial burdens when seeking treatment abroad.
2026-06-08
With advanced cardiovascular technologies, experienced specialists, innovative therapies, and competitive treatment costs, China is becoming an increasingly attractive destination for international patients seeking heart disease treatment.
2026-06-08
Advances in gene therapy, RNA-targeted therapies, and enzyme replacement treatments are transforming rare disease care worldwide. Learn how international healthcare services are helping patients access innovative therapies and global medical resources.
2026-06-05
At ASCO 2026, 13 studies from 12 Chinese biopharma companies were selected for Plenary and Late-Breaking sessions, highlighting China's growing influence in global oncology innovation through PD-1/VEGF bispecific antibodies, IO 2.0 therapies, and next-generation bispecific ADCs.
2026-06-05
China's healthcare innovation sector is expanding rapidly, bringing new opportunities for patients to access innovative medicines, cell and gene therapies, precision medicine, and cutting-edge clinical research.
2026-06-04
CAR-T therapy is transforming cancer treatment, but costs can vary dramatically between countries, hospitals, and products. Learn what drives the price differences and how patients can make informed decisions.
2026-06-04
As cross-border healthcare becomes increasingly common, patients often rely on medical facilitators to navigate complex healthcare systems. Learn how to evaluate international healthcare service providers and why China is becoming a growing destination for medical treatment.
2026-06-04
As global medical resources continue to integrate, more and more patients are seeking cross-border medical services. This article outlines the process of booking foreign hospitals, preparing medical records, and planning the entire overseas medical journey.
2026-06-02
Learn which international health insurance providers are accepted by Chinese hospitals, how direct billing works, and what overseas patients should know before seeking medical treatment in China.
2026-06-01
China's healthcare system is attracting more international patients through precision medicine, innovative therapies, efficient care pathways, and cost advantages, accelerating the growth of medical tourism and cross-border healthcare.
2026-05-29
As GLP-1 demand explodes globally, China is rapidly becoming one of the world’s most important peptide manufacturing hubs.
2026-05-28
As global demand for GLP-1 therapies surges, the peptide API industry is rapidly transitioning from small-scale synthesis to industrialized manufacturing.
2026-05-21
China’s biopharmaceutical industry is entering a new phase driven by policy reform, innovation, and global expansion.
2026-05-20
China’s innovative drugs sector is accelerating global collaboration through policy support, clinical progress, and expanding outbound licensing activity.